Dados epidemiológicos de gestantes com COVID-19 em Sorocaba, São Paulo e Brasil

Iago Vinícius de Queiroz Vieira; Michele Ferreira de  Camargo; Janie Maria de  Almeida

doi:10.23925/1984-4840.2025v27a5

Authors

Iago Vinícius de Queiroz Vieira Pontifícia Universidade Católica de São Paulo. Faculdade de Ciências Médicas e da Saúde
Michele Ferreira de Camargo Pontifícia Universidade Católica de São Paulo. Faculdade de Ciências Médicas e da Saúde
Janie Maria de Almeida Pontifícia Universidade Católica de São Paulo. Faculdade de Ciências Médicas e da Saúde

DOI:

https://doi.org/10.23925/1984-4840.2025v27a5

Keywords:

COVID-19/epidemiology, Pregnancy Complications, Infectious, Pregnancy

Abstract

Objective: This article aims to investigate the epidemiological data on COVID-19 in pregnant women at national, state, and municipal levels. Methodology: Data from the Brazilian Obstetric Observatory (OOBr) between 2020 and June 2022 were analyzed. A descriptive analysis was performed to integrate the data, complemented by Tukey's Test for Multiple Proportion Comparisons, as described by Zar, considering p-values below 0.05 as significant. Results: Between March 2020 and June 2022, Brazil reported 22,245 cases and 2,031 deaths from severe COVID-19 in pregnant women, with the mortality peak occurring in 2021. Young women aged 20 to 34 years, with a high school education and predominantly of mixed race, were the most affected. Black women showed higher rates of complications and mortality, reflecting the impact of structural racism, unfavorable socioeconomic conditions, and limited access to healthcare services. The third trimester of pregnancy emerged as the period of highest vulnerability. Conclusion: The analysis revealed that young, mixed-race, and Black pregnant women were the most affected by COVID-19, highlighting social and racial inequalities. The third trimester was identified as the highest-risk period, with worsening conditions in 2021 due to low vaccination rates but improvements in 2022 following mass immunization. The study underscores the need for public policies to ensure equitable access to healthcare and combat misinformation.

Downloads

Download data is not yet available.

Metrics

No metrics found.

References

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;58(4):711–2. doi: 10.1056/NEJMoa2002032.

Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20(5):270–84. doi: 10.1038/ s41579-022-00713-0.

Overton EE, Goffman D, Friedman AM. The epidemiology of COVID-19 in pregnancy. Clin Obstet Gynecol. 2022;65(1):110–22. doi: 10.1097/GRF.0000000000000674.

Allen DW. COVID-19 lockdown cost/benefits: a critical assessment of the literature. Int J Econ Business 2022;29(1):1–32. doi: 10.1080/13571516.2021.1976051.

Secretaria da Saúde de São Paulo (BR). Vacinômetro, vacina já e vacivida [Internet]. 2022 [acesso em 10 jan. 2024]. Disponível em: https://vacinaja.sp.gov.br/vacinometro/

Torres-Torres J, Martinez-Portilla R, Spino-Y-Sosa S, Estrada-Gutierrez G, Solis-Paredes J, Villafan-Bernal JR et al. Comorbidity, poverty and social vulnerability as risk factors for mortality in pregnant women with confirmed SARS-CoV-2 infection: analysis of 13 062 positive pregnancies including 176 maternal deaths in Mexico. Ultrasound Obstet Gynecol. 2021;59:76–82. doi: 10.1002/uog.24797.

Qeadan F, Mensah NA, Tingey B, Stanford JB. The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis. BMC Pregnancy Childbirth. 2021;21(1):305. doi: 10.1186/s12884-021-03772-y.

Narang K, Enninga EAL, Gunaratne MDSK, Madugodaralalage DSK, Gunaratne, MBBS, Eniola R et al. SARS-CoV-2 iInfection and COVID-19 during pregnancy: a multidisciplinary review. Mayo Clin Proc. 2020;95(8):1750–65. doi: 10.1016/j.mayocp.2020.05.011.

Serra FE, Francisco RPV, Rossi P, Brizot ML, Rodrigues AS. COVID-19 outcomes in hospitalized puerperal, pregnant, and neither pregnant nor puerperal women. Plos One. 2021;16(11): e0259911. doi: 10.1371/journal.pone.0259911.

Brasil. Ministério da Saúde. Manual de recomendações para a assistência à gestante e puérpera frente à pandemia de COVID-19. 2ª ed. Brasília (DF): Ministério da Saúde; 2021.

Observatório Obstétrico Brasileiro. OOBr SRAG: Síndrome respiratória aguda grave em gestantes e puérperas [Internet]. 2021 [acesso em 13 ago 2023]. Disponível em: https://observatorioobstetrico.shinyapps.io/covid_gesta_puerp_br

Zar JH. Biostatistical analysis. Vol. 5. New Jersey: Pearson; 2010.

Brito JGE, Alencar CCA, Lemos, AC, Caetano CLR, Menezes MO, Barreiro MSC. Características clínicas, sociodemográficas e desfechos de gestantes hospitalizadas com COVID-19. Res Soc Dev. 2021;10(17): e33101723049. doi: 10.33448/rsd-v10i17.23049.

Barbosa Filho MC, Lopes FNB, Viana JFS, Ferreira BO. Síndrome respiratória aguda grave por COVID-19: perfil epidemiológico em gestantes e puérperas no Amazonas. Medicina (Ribeirão Preto). 2022;55(2):1-10. doi: 10.11606/issn.2176-7262.rmrp.2022.194706.

Wheeler JM, Misra DP, Giurescu C. Stress and coping among pregnant black women during the COVID-19 pandemic. Public Health Nurs. 2021;38:596–602. doi: 10.1111/phn.12909.

Góes EF, Ferreira AJF, Ramos D. Racismo antinegro e morte materna por COVID-19: o que vimos na Pandemia? Ciênc Saúde Coletiva. 2023;28(9):2501–10. doi: 10.1590/1413-81232023289.08412022.

Santos FBD, Silva SLBD. Gênero, raça e classe no Brasil: os efeitos do racismo estrutural e institucional na vida da população negra durante a pandemia da COVID-19. Rev Direito Práx. 2022;13(3):1847–73. doi: 10.1590/2179-8966/2022/68967.

Naurin E, Markstedt E, Stolle D, Enström D, Wallin A, Andreasson I et al. Pregnant under the pressure of a pandemic: a large-scale longitudinal survey before and during the COVID-19 outbreak. Eur J Public Health. 2021;31(1):7–13. doi: 10.1093/eurpub/ckaa223.

Parra-Saavedra M, Villa-Villa I, Pérez-Olivo J, Guzman-Polania L, Galvis-Centurion P, Cumplido-Romero A et al. Attitudes and collateral psychological effects of COVID-19 in pregnant women in Colombia. Int Gynecol Obstet. 2020;203–8. doi: 10.1002%2Fijgo.13348.

Souza ASR, Amorim MMR. Maternal mortality by COVID-19 in Brazil. Rev Bras Saude Mater Infant. 2021;21(suppl 1):253–6. doi: 10.1590/1806-9304202100S100014.

Bergantini LS, Ichisato SMT, Salci MA, Birolim MM, Santos MLAD, Höring CF, et al. Fatores associados a hospitalizações e óbitos de gestantes paranaenses por COVID-19: estudo transversal. Rev Bras Epidemiol. 2024;27:e240005. doi: 10.1590/1980-549720240005.2.

Mohammed I, Nauman A, Paul P, Ganesan S, Chen KH, Jalil SMS, et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Hum Vaccin Immunother. 2022;18(1):2027160. doi: 10.1080/21645515.2022.2027160.